Bio-Techne Co. (NASDAQ:TECH) Given Average ... - ETF Daily News

Dec 25, 2024 · Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are covering the stock, Marketbeat.com ...

5%
OFF

Bio-Techne Co. (NASDAQ:TECH) Given Consensus Rating Of

2 weeks from now

Dec 25, 2024 · Bio-Techne's quarterly revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.35 earnings per …

marketbeat.com

$73.79
OFF

JPMorgan Chase & Co. Reduces Stock Holdings In Bio ... - ETF …

2 weeks from now

Jan 4, 2025 · Bio-Techne Trading Up 3.2 %. Shares of TECH opened at $73.79 on Friday. The company has a quick ratio of 3.26, a current ratio of 4.56 and a debt-to-equity ratio of 0.14. …

etfdailynews.com

$74.57
OFF

Stifel Financial Corp Acquires 3,731 Shares Of Bio ... - ETF Daily News

2 weeks from now

Dec 18, 2024 · Read Stifel Financial Corp Acquires 3,731 Shares of Bio-Techne Co. (NASDAQ:TECH) at ETF Daily News ... average price is $74.57. Bio-Techne Co. has a 52 …

etfdailynews.com

06%
OFF

Bio-Techne Corporation (TECH) Stock Price, Quote & News - Stock …

2 weeks from now

Jan 8, 2025 · According to 8 analysts, the average rating for TECH stock is "Buy." The 12-month stock price forecast is $82.0, which is an increase of 9.06% from the latest price. ... Bio …

stockanalysis.com

$74.57
OFF

HighTower Advisors LLC Reduces Position In Bio-Techne ... - ETF …

2 weeks from now

Dec 18, 2024 · Read HighTower Advisors LLC Reduces Position in Bio-Techne Co. (NASDAQ:TECH) at ETF Daily News. ... two-hundred day moving average is $74.57. Bio …

etfdailynews.com

0%
OFF

Bio-Techne Co. (NASDAQ:TECH) Shares Acquired By Broadcrest …

2 weeks from now

Nov 17, 2024 · Broadcrest Asset Management LLC raised its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 100.0% in the 3rd quarter, according to its most recent 13F …

marketbeat.com

7%
OFF

Biotech Stocks Put Up A Split Showing At JPM - Investor's …

2 weeks from now

2 days ago · Harmony Bio, a frequent contender among the top five biotech stocks, surged 7.7% to 36.45. BridgeBio stock broke out of a cup-with-handle base , topping an entry at 30.51.

investors.com

$74.87
OFF

Fmr LLC Grows Stock Position In Bio-Techne Co. (NASDAQ:TECH)

2 weeks from now

Dec 5, 2024 · Read Fmr LLC Grows Stock Position in Bio-Techne Co. (NASDAQ:TECH) at ETF Daily News ... day moving average of $74.87. Bio-Techne Co. has a 52-week low of $61.16 …

etfdailynews.com

$82.00
OFF

Bio-Techne (TECH) Stock Forecast And Price Target 2024

2 weeks from now

Dec 31, 2024 · According to the 8 analysts' twelve-month price targets for Bio-Techne, the average price target is $82.00. The highest price target for TECH is $95.00, while the lowest …

marketbeat.com

$72.98
OFF

Bio-Techne Co. (NASDAQ:TECH) Sees Significant Decrease In Short ...

2 weeks from now

Dec 30, 2024 · Shares of Bio-Techne stock opened at $72.98 on Monday. Bio-Techne has a twelve month low of $61.16 and a twelve month high of $85.57. The firm’s 50-day moving …

etfdailynews.com

16%
OFF

Head-To-Head Comparison: Elevation Oncology (NASDAQ ... - ETF …

2 weeks from now

6 days ago · Elevation Oncology presently has a consensus price target of $7.20, indicating a potential upside of 855.16%. Bio-Techne has a consensus price target of $82.00, indicating a …

etfdailynews.com

$74.25
OFF

Everence Capital Management Inc. Sells 2,750 Shares Of Bio …

2 weeks from now

Jan 7, 2025 · Get Our Latest Analysis on TECH. Bio-Techne Trading Up 0.6 %. NASDAQ TECH opened at $74.25 on Tuesday. The firm has a market cap of $11.80 billion, a PE ratio of 78.99, …

etfdailynews.com

$8.14
OFF

JPMorgan Chase & Co. Has $8.14 Million Stake In Vir ... - MarketBeat

2 weeks from now

1 day ago · In other news, Director Vicki L. Sato sold 10,960 shares of the company's stock in a transaction dated Wednesday, January 8th. The shares were sold at an average price of …

marketbeat.com

4%
OFF

Bio-Techne Co. (NASDAQ:TECH) Shares Bought By Mirae ... - ETF …

2 weeks from now

Nov 2, 2024 · Mirae Asset Global Investments Co. Ltd. increased its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 38.4% in the third quarter, according to its most recent …

etfdailynews.com

2%
OFF

Bio-Techne Co. (NASDAQ:TECH) Shares Sold By Truist Financial Corp

2 weeks from now

Oct 13, 2024 · Truist Financial Corp decreased its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 2.2% in the 2nd quarter, according to the company in its most recent filing …

etfdailynews.com

FAQs about Bio-Techne Co. (NASDAQ:TECH) Given Average ... - ETF Daily News Coupon?

Should you buy Bio-Techne (tech) stock in 2024?

In 2024, Bio-Techne's revenue was $1.16 billion, an increase of 1.97% compared to the previous year's $1.14 billion. Earnings were $168.07 million, a decrease of -41.07%. According to 8 analysts, the average rating for TECH stock is "Buy." The 12-month stock price forecast is $82.0, which is an increase of 14.72% from the latest price. ...

What is the 12-month price forecast for Bio-Techne Corporation (Tech)?

The 12-month stock price forecast is $82.0, which is an increase of 14.72% from the latest price. MINNEAPOLIS , Dec. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan... ...

Is Bio-Techne (bio) a great stock to buy?

Bio-Techne has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. ...

Who owns Bio-Techne (Tech)?

Finally, DT Investment Partners LLC purchased a new position in Bio-Techne in the 2nd quarter valued at $36,000. 98.95% of the stock is currently owned by hedge funds and other institutional investors. Shares of NASDAQ:TECH opened at $76.02 on Friday. ...

When did Bio-Techne (Tech) release its quarterly earnings?

Bio-Techne (NASDAQ:TECH – Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The biotechnology company reported $0.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.04. ...

How much money does Bio-Techne make?

Bio-Techne (NASDAQ:TECH) has a market capitalization of $11.31 billion and generates $1.11 billion in revenue each year. The biotechnology company earns $272.05 million in net income (profit) each year or $1.61 on an earnings per share basis. How many employees does Bio-Techne have? The company employs 3,000 workers across the globe. ...